1. Allicin, a Potent New Ornithine Decarboxylase Inhibitor in Neuroblastoma Cells
- Author
-
Schultz, Chad R., Gruhlke, Martin C. H., Slusarenko, Alan J., and Bachmann, André S.
- Abstract
The natural product allicin is a reactive sulfur species (RSS) from garlic (Allium sativumL.). Neuroblastoma (NB) is an early childhood cancer arising from the developing peripheral nervous system. Ornithine decarboxylase (ODC) is a rate-limiting enzyme in the biosynthesis of polyamines, which are oncometabolites that contribute to cell proliferation in NB and other c-MYC/MYCN-driven cancers. Both c-MYC and MYCN directly transactivate the E-box gene ODC1, a validated anticancer drug target. We identified allicin as a potent ODC inhibitor in a specific radioactive in vitroassay using purified human ODC. Allicin was ∼23 000-fold more potent (IC50= 11 nM) than DFMO (IC50= 252 μM), under identical in vitroassay conditions. ODC is a homodimer with 12 cysteines per monomer, and allicin reversibly S-thioallylates cysteines. In actively proliferating human NB cells allicin inhibited ODC enzyme activity, reduced cellular polyamine levels, inhibited cell proliferation (IC509–19 μM), and induced apoptosis. The natural product allicin is a new ODC inhibitor and could be developed for use in conjunction with other anticancer treatments, the latter perhaps at a lower than usual dosage, to achieve drug synergism with good prognosis and reduced adverse effects.
- Published
- 2020
- Full Text
- View/download PDF